Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Family Medicine · SPARTA, TN · NPI 1174512974
Verified facts
CMS Open Payments records show Ty T Webb, MD received $15.00 in general payments during 2025 across 1 reported records.
Medtronic, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$15.00 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $15.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MINIMED 780G Normalized: minimed 780g |
Device | Medtronic, Inc. | $15.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 413 | 125 |
| Lisinopril | Lisinopril | 311 | 107 |
| Levothyroxine Sodium | Levothyroxine Sodium | 285 | 84 |
| Atorvastatin Calcium | Atorvastatin Calcium | 274 | 89 |
| Pantoprazole Sodium | Pantoprazole Sodium | 268 | 91 |
| Metformin Hcl | Metformin Hcl | 251 | 78 |
| Gabapentin | Gabapentin | 248 | 56 |
| Amlodipine Besylate | Amlodipine Besylate | 221 | 73 |
| Furosemide | Furosemide | 207 | 61 |
| Losartan Potassium | Losartan Potassium | 203 | 60 |
| Alprazolam | Alprazolam | 164 | 28 |
| Potassium Chloride | Potassium Chloride | 160 | 58 |
| Hydrochlorothiazide | Hydrochlorothiazide | 158 | 51 |
| Omeprazole | Omeprazole | 151 | 44 |
| Tamsulosin Hcl | Tamsulosin Hcl | 150 | 47 |
| Montelukast Sodium | Montelukast Sodium | 149 | 44 |
| Metoprolol Succinate | Metoprolol Succinate | 148 | 48 |
| Sertraline Hcl | Sertraline Hcl | 124 | 48 |
| Prednisone | Prednisone | 118 | 54 |
| Tramadol Hcl | Tramadol Hcl | 118 | 31 |
| Carvedilol | Carvedilol | 113 | 35 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 112 | 21 |
| Ozempic | Semaglutide | 109 | 16 |
| Atenolol | Atenolol | 98 | 31 |
| Famotidine | Famotidine | 98 | 31 |
| Metoprolol Tartrate | Metoprolol Tartrate | 89 | 28 |
| Diazepam | Diazepam | 87 | 22 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 86 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 81 | 27 |
| Jardiance | Empagliflozin | 80 | 17 |
| Xarelto | Rivaroxaban | 78 | 15 |
| Eliquis | Apixaban | 77 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 71 | 16 |
| Clonazepam | Clonazepam | 70 | 14 |
| Trazodone Hcl | Trazodone Hcl | 69 | 25 |
| Zolpidem Tartrate | Zolpidem Tartrate | 68 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 66 | 22 |
| Simvastatin | Simvastatin | 65 | 21 |
| Allopurinol | Allopurinol | 64 | 18 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 62 | 20 |
| Meloxicam | Meloxicam | 62 | 20 |
| Tizanidine Hcl | Tizanidine Hcl | 62 | 25 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 60 | 21 |
| Warfarin Sodium | Warfarin Sodium | 59 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 52 | 12 |
| Glimepiride | Glimepiride | 51 | 20 |
| Anastrozole | Anastrozole | 48 | 15 |
| Farxiga | Dapagliflozin Propanediol | 48 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 48 | 25 |
| Trulicity | Dulaglutide | 46 | suppressed |
| Aripiprazole | Aripiprazole | 45 | 13 |
| Fluconazole | Fluconazole | 45 | 32 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 44 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 44 | 33 |
| Nebivolol Hcl | Nebivolol Hcl | 43 | 13 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 42 | 23 |
| Imiquimod | Imiquimod | 42 | 34 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 41 | 28 |
| Pioglitazone Hcl | Pioglitazone Hcl | 40 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 37 | 25 |
| Bupropion Xl | Bupropion Hcl | 36 | suppressed |
| Celecoxib | Celecoxib | 36 | 14 |
| Nifedipine Er | Nifedipine | 36 | 15 |
| Azithromycin | Azithromycin | 35 | 28 |
| Nystatin | Nystatin | 35 | 19 |
| Pregabalin | Pregabalin | 35 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 33 | suppressed |
| Memantine Hcl | Memantine Hcl | 32 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 32 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 32 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 31 | 29 |
| Fluticasone Propionate | Fluticasone Propionate | 30 | 14 |
| Lovastatin | Lovastatin | 30 | suppressed |
| Spironolactone | Spironolactone | 30 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 29 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 29 | suppressed |
| Nitroglycerin | Nitroglycerin | 29 | 12 |
| Buspirone Hcl | Buspirone Hcl | 28 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 28 | 15 |
| Irbesartan | Irbesartan | 28 | suppressed |
| Lamotrigine | Lamotrigine | 28 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 27 | 11 |
| Estradiol | Estradiol | 27 | 13 |
| Ezetimibe | Ezetimibe | 27 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 26 | suppressed |
| Sotalol | Sotalol Hcl | 26 | suppressed |
| Kerendia | Finerenone | 25 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 25 | suppressed |
| Minoxidil | Minoxidil | 25 | 12 |
| Dutasteride | Dutasteride | 24 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 24 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 22 | 22 |
| Pravastatin Sodium | Pravastatin Sodium | 22 | suppressed |
| Verapamil Er | Verapamil Hcl | 22 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 21 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 21 | suppressed |
| Mounjaro | Tirzepatide | 21 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 21 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 20 | suppressed |
| Methotrexate | Methotrexate Sodium | 20 | suppressed |
| Mupirocin | Mupirocin | 20 | 13 |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 20 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 20 | suppressed |
| Ramipril | Ramipril | 20 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 19 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 19 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 19 | suppressed |
| Myrbetriq | Mirabegron | 19 | suppressed |
| Premarin | Estrogens, Conjugated | 19 | suppressed |
| Valsartan | Valsartan | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 18 | suppressed |
| Lorazepam | Lorazepam | 18 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 18 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 17 | suppressed |
| Bumetanide | Bumetanide | 17 | suppressed |
| Cephalexin | Cephalexin | 17 | 13 |
| Entresto | Sacubitril/Valsartan | 17 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 16 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Risperidone | Risperidone | 16 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 15 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 15 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 15 | suppressed |
| Ranolazine Er | Ranolazine | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Cefdinir | Cefdinir | 14 | 11 |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 14 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Colchicine | Colchicine | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Prolia | Denosumab | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Easy-Touch Insulin Syringe | Syringe And Needle,insulin,1ml | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Januvia | Sitagliptin Phosphate | 12 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 12 | suppressed |
| Synthroid | Levothyroxine Sodium | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 11 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Ibuprofen | Ibuprofen | 11 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
| Novolin R | Insulin Regular, Human | 11 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 11 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $15.00 · 1 records | Medtronic, Inc. | MINIMED 780G | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error